EG110A received FDA fast track designation to treat neurogenic detrusor overactivity, a bladder issue common in MS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback